Ocala Royal Dames funds four innovative cancer research projects
Four researchers each received $25,000 from the Ocala Royal Dames for Cancer Research.
Posts tagged as
The Herbert Wertheim UF Scripps Institute For Biomedical Innovation & Technology
With NCI designation, UF Health Cancer Center accelerates research impact
On the anniversary of achieving NCI designation, a look at 10 key achievements over the past year.
UF Health Cancer Center funds five collaborative studies with The Wertheim UF Scripps Institute
The projects harness the strengths of the University of Florida with The Herbert Wertheim UF Scripps Florida Institute for Biomedical Innovation and Technology.
UF Scripps researcher receives NCI grant to study breast cancer therapies
The project aims to understand the molecular mechanisms of how different classes of estrogen receptor antagonists inhibit breast cancer growth.
Climbing a new path allows chemists to ascend cancer’s steepest research challenges
A collaboration including The Wertheim UF Scripps Institute vastly expands the catalog of potential RNA-targeted medicines.
Research Snapshot: UF Scripps team develops method to study lung cancer models using natural products
The team developed an effective and cost-efficient method for 3D screening of lung cancer spheroids.
First ‘Institute Professor’ of The Wertheim UF Scripps Institute inventing new ways to target incurable diseases via RNA
Matthew D. Disney, Ph.D., has been named the first “Institute Professor” at The Wertheim UF Scripps Institute.
Wertheim UF Scripps Institute researchers make major advance with cancer-killing antibody-drug conjugates
UF researchers have made a significant discovery in the effort to develop potent, highly targeted chemotherapies for breast and other cancers.
UF Scripps researcher’s drug-discovery method shows promise against aggressive breast cancer
UF Scripps Biomedical Research scientist Matthew Disney, Ph.D. has found yet another groundbreaking approach to a problem that has long vexed scientists: How to cure diseases by targeting key RNA.
